Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) EBT: 2009-2024

Historic EBT for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to -$19.4 million.

  • OptimizeRx's EBT rose 11055.23% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 10505.82%. This contributed to the annual value of -$19.4 million for FY2024, which is 2296.53% up from last year.
  • OptimizeRx's EBT amounted to -$19.4 million in FY2024, which was up 2296.53% from -$25.2 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's EBT ranged from a high of $378079.0 in FY2021 and a low of -$25.2 million during FY2023
  • Over the past 5 years, OptimizeRx's median EBT value was -$11.4 million (recorded in 2022), while the average stood at -$11.6 million.
  • Per our database at Business Quant, OptimizeRx's EBT soared by 11712.99% in 2021 and then tumbled by 312541.0% in 2022.
  • Over the past 5 years, OptimizeRx's EBT (Annual) stood at -$2.2 million in 2020, then surged by 117.13% to $378079.0 in 2021, then plummeted by 3125.41% to -$11.4 million in 2022, then tumbled by 120.0% to -$25.2 million in 2023, then increased by 22.97% to -$19.4 million in 2024.
  • Its last three reported values are -$19.4 million in FY2024, -$25.2 million for FY2023, and -$11.4 million during FY2022.